Advertisement
Home »

Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.

Jan 01, 2024

ABOUT THE EXPERTS

  • Xue-Zhu Feng

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China; Department of Neurobiology, Peking University Health Science Center, Beijing 100191, China.

    Zhe Li

    School of Social Development and Public Policy (SSDPP), Beijing Normal University, Beijing 100875, China.

    Zi-Yi Li

    Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Translation Medicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.

    Ke Wang

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China.

    Xuan Tan

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China; Department of Neurobiology, Peking University Health Science Center, Beijing 100191, China.

    Yu-Yu Zhao

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China; Department of Neurobiology, Peking University Health Science Center, Beijing 100191, China.

    Wei-Feng Mi

    Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Centre for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.

    Wei-Li Zhu

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China.

    Yan-Ping Bao

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China.

    Lin Lu

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Centre for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China; Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China; Research Unit of Diagnosis and Treatment of Mood Cognitive Disorder, Chinese Academy of Medical Sciences (No.2018RU006), Beijing, China.. Electronic address: linlu@bjmu.edu.cn.

    Su-Xia Li

    National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, 38 Xue Yuan Road, Haidian District, Beijing 100191, China. Electronic address: li313@bjmu.edu.cn.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement